---

PT-141 (Bremelanotide) – Research Grade Lyophilized Peptide

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist widely studied in neuroendocrine and behavioral research. Originally developed from melanocortin peptide analogs related to α-melanocyte-stimulating hormone (α-MSH), the compound has drawn scientific attention for its ability to interact with melanocortin receptors located throughout the central nervous system. These receptors are involved in numerous physiological pathways including energy balance, mood, and sexual arousal signaling, making the peptide an important tool in laboratory research exploring neurochemical regulation and behavioral responses.

Unlike compounds that primarily influence peripheral vascular mechanisms, this molecule is studied for its central nervous system activity. Research suggests that melanocortin receptor activation, particularly at MC3R and MC4R receptor sites, plays a role in modulating neural pathways involved in arousal, reward, and motivational signaling. Experimental work indicates that the peptide functions as an agonist at several melanocortin receptor subtypes, which are distributed in regions of the brain associated with autonomic and behavioral regulation.

Because of this mechanism, scientists often examine the compound within models of neurobehavioral signaling and endocrine interaction. Its receptor-mediated activity has made it a point of interest for investigations into melanocortin signaling pathways and their broader role in central nervous system function.

---

Research Overview

Within experimental models, Pt-141 has been investigated for its interaction with melanocortin-4 receptor (MC4R) signaling, one of the receptor subtypes strongly associated with behavioral and neurological responses. Activation of these receptors has been linked to changes in neurotransmitter signaling pathways that regulate motivational and reward-related behaviors.

Preclinical and clinical studies have explored how melanocortin receptor agonists influence physiological responses tied to arousal pathways and neurochemical signaling. These studies have demonstrated that melanocortin agonists can activate central pathways independently of the peripheral nitric-oxide-mediated mechanisms commonly associated with vascular responses.

Researchers continue to examine Pt-141 in laboratory settings to better understand how melanocortin receptor activation influences complex neurobiological processes. Areas of interest include behavioral neuroendocrinology, receptor pharmacology, and peptide signaling pathways.

For example, a study published in the Annals of the New York Academy of Sciences describes the compound as a melanocortin receptor agonist derived from α-MSH analogs, emphasizing its interaction with melanocortin receptors in the central nervous system.

You can review this research publication here:
https://pubmed.ncbi.nlm.nih.gov/12851303/

---

Peptide Structure and Mechanism of Interest

Pt-141 is classified as a cyclic heptapeptide melanocortin agonist, structurally related to naturally occurring melanocortin peptides involved in pigmentation, appetite regulation, and endocrine signaling. Research indicates that these peptides exert their biological effects through G-protein-coupled melanocortin receptors distributed across the brain and peripheral tissues.

When melanocortin receptors are activated in experimental models, downstream signaling cascades may influence neurotransmitter systems associated with motivation and behavioral responses. Because of these interactions, Pt-141 is frequently used as a research probe for melanocortin receptor activity.

In laboratory environments, melanocortin peptides provide valuable insight into receptor signaling pathways and the physiological processes regulated by neuropeptide communication within the central nervous system.

---

Laboratory Preparation and Reconstitution

As with most lyophilized peptides used in laboratory environments, proper preparation is essential for accurate experimental work. Pt-141 is supplied as a research-grade lyophilized powder, which helps preserve stability during transport and storage.

Before experimental use, researchers typically reconstitute lyophilized peptides using sterile bacteriostatic or laboratory-grade water under controlled conditions. This process allows the peptide to return to solution form for accurate volumetric measurement during laboratory procedures.

If you require guidance on peptide dilution calculations or laboratory preparation methods, please refer to our detailed internal resource:

Reconstitution Guide:
https://nutrigenixscientific.com/2026/03/10/reconstitution-guide/

This guide outlines standard laboratory preparation techniques commonly used when handling lyophilized research peptides.

---

Quality and Research Standards

Each batch is manufactured under controlled laboratory conditions and undergoes analytical verification to confirm identity and purity. Lyophilization is performed to maintain peptide stability and facilitate reliable storage prior to laboratory use.

Typical quality control procedures for research peptides may include:

• High-performance liquid chromatography (HPLC) analysis
• Mass spectrometry identity confirmation
• Batch traceability and documentation
• Controlled temperature storage conditions

These analytical procedures help ensure that researchers receive a consistent compound suitable for laboratory investigation.

---

Research Use Notice

This product is supplied strictly for laboratory research and analytical purposes only. It is not intended for human consumption, medical use, veterinary use, or therapeutic application. By purchasing this material, the buyer affirms that it will be handled only by qualified professionals familiar with laboratory peptide handling, storage, and disposal procedures.